POSTER REVIEW ABSTRACTS' Soft tissue sarcomas - PowerPoint PPT Presentation

1 / 7
About This Presentation
Title:

POSTER REVIEW ABSTRACTS' Soft tissue sarcomas

Description:

POSTER REVIEW ABSTRACTS. Soft tissue sarcomas. Ignacio Azinovic. USP Hospital San Jaime ... No clear factors for local control. Systemic disease (high grade STS) ... – PowerPoint PPT presentation

Number of Views:41
Avg rating:3.0/5.0
Slides: 8
Provided by: ignacioa
Category:

less

Transcript and Presenter's Notes

Title: POSTER REVIEW ABSTRACTS' Soft tissue sarcomas


1
POSTER REVIEW ABSTRACTS.Soft tissue sarcomas
  • Ignacio Azinovic
  • USP Hospital San Jaime
  • Torrevieja. Alicante. Spain

5th ISIORT. Madrid 2008
2
8 poster abstracts
  • Institutional experiences (7/8)
  • 4 papers HGUGM. 73 patients
  • Institutional experience.
  • Miscelaneous
  • Extremities
  • Retroperitoneal
  • 1 paper Mayo Arizona. 80 patients (48 w IOERT)
  • 1 paper Ramon Cajal , Madrid. 29 patients
  • 1 paper. Aggresive fibromatosis. 28 patients
  • Investigational report

3
Results. Madrid experience
  • IOERT as boost given during surgery
  • Local failure rates are low
  • Extremities/trunk 10-20
  • Retroperitoneal 41
  • Hospital Ramon y Cajal. Short f/u.
  • The problem of surgical margins
  • Histology
  • Good functional outcome. 83 limb sparing.
  • Systemic disease

4
Mayo- Arizona
  • Preoperative radiotherapy
  • 48 patients. Diameter (median) 8, 5 cm
  • Extremities and trunk
  • Neoadjuvant Chemo 16 p
  • Concurrent 20p
  • Local relapses 4 (8)
  • 16 p (33) wound complications
  • No clear factors for local control
  • Systemic disease (high grade STS) as a problem in
    management.

5
Aggresive fibromatosis (n 28)Heidelberg
  • IOERT 12 Gy
  • EBRT 45 Gy (36-54)
  • Margins close 6 micro11 macro 11.
  • 5 local recurrences (19)
  • Residual disease, presentation (primary or
    recurrent), size or location showed no impact on
    local control.

6
Biological modelling. Ramon y Cajal. Madrid
  • IOERT, HDR, EBRT
  • LQ model.
  • Improve the thepapeutic ratio
  • Best strategy
  • IOERT (9 Gy) HDRBT (10 x 3,4 Gy, 5 d)
  • Worst strategy IOERT EBRT

7
Personal thoughts for expanding IOERT in STS
  • The patterns of failure are well established
  • Toxicity profile is acceptable, no neuropathies.
  • Prognostic factors from pooled analysis and
    institutional experiences should help us to move
    forward.
  • Improve therapeutic ratio. Dose escalation
  • IMRT to the margin
  • HDR
  • Chemotherapy (Concurrent)
Write a Comment
User Comments (0)
About PowerShow.com